PATH vs TMHC · P/E 19, rev $1.61B vs P/E 11, rev $8.17B
Uipath Inc (PATH) versus Taylor Morn Home (TMHC) — a side-by-side from cached financials, not a winner call.
Uipath Inc (PATH) is a software - infrastructure company listed on US.
Taylor Morn Home (TMHC) is a residential construction company listed on NYSE.
Latest reported PATH revenue for 2026-01-31 was $1.61B. Net income was $282.3M. Revenue was up 12.7% from 2025-01-31 to 2026-01-31. PATH currently screens at market cap $6.07B and trailing P/E 19.4.
Latest reported TMHC revenue for 2024-12-31 was $8.17B. Net income was $886.6M. Revenue was up 10.1% from 2023-12-31 to 2024-12-31. TMHC currently screens at market cap $6.59B and trailing P/E 10.7.
PATH currently screens at market cap $6.07B and trailing P/E 19.4. TMHC currently screens at market cap $6.59B and trailing P/E 10.7.
Not investment advice. Open the PATH and TMHC stock pages for the full models.
Not investment advice.